ArticleThe Journal of investigative dermatologyPublished
A Phase 2, Randomized, Placebo-Controlled Study of Bermekimab in Moderate-to-Severe Hidradenitis Suppurativa
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- The Journal of investigative dermatology
- Published
- Topic
- Clinical care
- Subject terms
- Safety; efficacy; Hidradenitis Suppurativa; Bermekimab; Hidradenitis Suppurativa Clinical Response
- PubMed ID
- 40865678
- Added to directory
- Source checked